Process for preparing a COT inhibitor compound
Disclosed are syntheses of a Cot (cancer Osaka thyroid) inhibitor, which has the following formula:.
Saved in:
Main Authors | , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
16.01.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Disclosed are syntheses of a Cot (cancer Osaka thyroid) inhibitor, which has the following formula:. |
---|---|
AbstractList | Disclosed are syntheses of a Cot (cancer Osaka thyroid) inhibitor, which has the following formula:. |
Author | STEVENS, ANDREW C YU, GUOJUN DEMPAH, KASSIBLA E CHAN, LINA ALLAN, KEVIN M LI, JESSE W EBERLE, KELLY J VOICA, ANA F HAGGERTY, KEVIN D ELFORD, TIMOTHY G DEIGNAN, JEFFREY T NIU, TIANMIN WILLIAMSON, KEVIN S CHTELININE, ANDREI ELFGREN, DANIELLE M XU, BORAN |
Author_xml | – fullname: VOICA, ANA F – fullname: WILLIAMSON, KEVIN S – fullname: ELFGREN, DANIELLE M – fullname: HAGGERTY, KEVIN D – fullname: CHTELININE, ANDREI – fullname: CHAN, LINA – fullname: EBERLE, KELLY J – fullname: XU, BORAN – fullname: YU, GUOJUN – fullname: STEVENS, ANDREW C – fullname: DEIGNAN, JEFFREY T – fullname: DEMPAH, KASSIBLA E – fullname: ALLAN, KEVIN M – fullname: LI, JESSE W – fullname: ELFORD, TIMOTHY G – fullname: NIU, TIANMIN |
BookMark | eNrjYmDJy89L5WTQCyjKT04tLlZIyy9SKChKLUgsysxLV0hUcPYPUcjMy8hMyiwByiTn5xbkl-al8DCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSS-JBwIwMjIDKxNHA0JkYNAMqiLBM |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | TW202202490A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_TW202202490A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:50:16 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Chinese English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_TW202202490A3 |
Notes | Application Number: TW202110111737 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220116&DB=EPODOC&CC=TW&NR=202202490A |
ParticipantIDs | epo_espacenet_TW202202490A |
PublicationCentury | 2000 |
PublicationDate | 20220116 |
PublicationDateYYYYMMDD | 2022-01-16 |
PublicationDate_xml | – month: 01 year: 2022 text: 20220116 day: 16 |
PublicationDecade | 2020 |
PublicationYear | 2022 |
RelatedCompanies | GILEAD SCIENCES, INC |
RelatedCompanies_xml | – name: GILEAD SCIENCES, INC |
Score | 3.4810233 |
Snippet | Disclosed are syntheses of a Cot (cancer Osaka thyroid) inhibitor, which has the following formula:. |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Process for preparing a COT inhibitor compound |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220116&DB=EPODOC&locale=&CC=TW&NR=202202490A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFfWmVdH6YAXJLbrpJqsegtg8KEIfSLS9lewabTzEkEYEf70zMbVe9La7A_uC2XnszDcAZ1wkGqWyNC1tS9NWz9xU-pqb8SW_Ug6-hpYmf0d_IHsP9t3EmTTgdZELU-GEflTgiMhRGvm9rN7rfOnE8qvYyvmFSnHo7SaMXN-oreMOiTNp-F03GA39oWd4nhuNjcH9Nw1NDX67AqukRhPOfvDYpayU_LdICbdgbYSzZeU2ND5nLdjwFpXXWrDerz-8sVnz3nwHzuuYfoZqJsuLhMoHZi8sZmiVszSbpQqZs2AUI06lknbhNAwir2fiwtOfU06j8XKPYg-aaP0n-8DkkyLMO42KgiKsM9QvlWNpmXAhHNGJD6D99zzt_4iHsEkd8idY8giaZfGeHKOELdVJdTVfL7l-Ig |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ7Uaqw3rZpaX2tiuKFLga0eiLFQglpoY9D2RtgVbT0goRgTf72zSK0XvW12ktlHMjuPnfkG4JTqiUCtzFRNGEw1-DNVubikatylF9zE11ATMt7hB8x7MG4n5qQGr4tamBIn9KMER0SJEijvRfleZ8sgllPmVs7P-Qyn3q7c0HKUyjvuSHXGFKdn9UdDZ2grtm2FYyW4_6ahq0GvV2C1K9F5pen02JNVKdlvleJuwtoIuaXFFtQ-p01o2IvOa01Y96sPbxxWsjffhrMqp5-gmUmyPJHtA9MXEhP0ysksnc44CmdOZI64bJW0AyduP7Q9FReOfk4ZhePlHvVdqKP3n7SAsCcuMe8EGgpcYp2hfclNTbCE6rqpd-I9aP_Np_0f8RgaXugPosFNcLcPG5IgYwsaO4B6kb8nh6htC35UXtMXPimBDw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Process+for+preparing+a+COT+inhibitor+compound&rft.inventor=VOICA%2C+ANA+F&rft.inventor=WILLIAMSON%2C+KEVIN+S&rft.inventor=ELFGREN%2C+DANIELLE+M&rft.inventor=HAGGERTY%2C+KEVIN+D&rft.inventor=CHTELININE%2C+ANDREI&rft.inventor=CHAN%2C+LINA&rft.inventor=EBERLE%2C+KELLY+J&rft.inventor=XU%2C+BORAN&rft.inventor=YU%2C+GUOJUN&rft.inventor=STEVENS%2C+ANDREW+C&rft.inventor=DEIGNAN%2C+JEFFREY+T&rft.inventor=DEMPAH%2C+KASSIBLA+E&rft.inventor=ALLAN%2C+KEVIN+M&rft.inventor=LI%2C+JESSE+W&rft.inventor=ELFORD%2C+TIMOTHY+G&rft.inventor=NIU%2C+TIANMIN&rft.date=2022-01-16&rft.externalDBID=A&rft.externalDocID=TW202202490A |